143 results on '"Korevaar, Sander S."'
Search Results
2. Interactions of the Immune System with Human Kidney Organoids.
3. Epigenetic changes in umbilical cord mesenchymal stromal cells upon stimulation and culture expansion
4. Monocytic Cells Phagocytose Therapeutic Mesenchymal Stem Cells, which Induces Polarization, Relocation and Immune Regulation
5. Kidney Organoids Are Capable of Forming Tumors, but Not Teratomas
6. Identification of predictive markers for the generation of well-differentiated human induced pluripotent stem cell-derived kidney organoids
7. Vitamin D metabolism in human kidney organoids
8. Membrane particles from mesenchymal stromal cells reduce the expression of fibrotic markers on pulmonary cells
9. Membrane Particles Derived From Adipose Tissue Mesenchymal Stromal Cells Improve Endothelial Cell Barrier Integrity
10. Membrane particles from mesenchymal stromal cells reduce the expression of fibrotic markers on pulmonary cells
11. Mesenchymal Stromal Cell Derived Membrane Particles Are Internalized by Macrophages and Endothelial Cells Through Receptor-Mediated Endocytosis and Phagocytosis
12. The effect of rabbit antithymocyte globulin on human mesenchymal stem cells
13. Differential effects of heat-inactivated, secretome-deficient MSC and metabolically active MSC in sepsis and allogenic heart transplantation
14. FOXP3+ REGULATORY T-CELLS PLAY A DOMINANT ROLE OVER RORγT+ TH17-CELLS IN DECEASED DONOR KIDNEYS: O-205
15. HUMAN MESENCHYMAL STEM CELLS ARE SUSCEPTIBLE FOR LYSIS BY CYTOTOXIC IMMUNE CELLS: O-57
16. HUMAN MESENCHYMAL STEM CELLS STIMULATE T-CELL PROLIFERATION AND GENERATE REGULATORY LYMPHOCYTES THAT INHIBIT ALLOREACTIVITY: O-36
17. Vitamin D metabolism in human kidney organoids.
18. The Importance of Dosing, Timing, and (in)Activation of Adipose Tissue-Derived Mesenchymal Stromal Cells on Their Immunomodulatory Effects.
19. Immunomodulation By Therapeutic Mesenchymal Stromal Cells (MSC) Is Triggered Through Phagocytosis of MSC By Monocytic Cells
20. Membrane particles generated from mesenchymal stromal cells modulate immune responses by selective targeting of pro-inflammatory monocytes
21. Inflammatory Conditions Dictate the Effect of Mesenchymal Stem or Stromal Cells on B Cell Function
22. Cytokine treatment optimises the immunotherapeutic effects of umbilical cord-derived MSC for treatment of inflammatory liver disease
23. Inflammatory Conditions Dictate the Effect of Mesenchymal Stem Cells on B Cell Function
24. Adipose Tissue-Derived Mesenchymal Stem Cells Have a Heterogenic Cytokine Secretion Profile
25. Inactivated Mesenchymal Stem Cells Maintain Immunomodulatory Capacity
26. Effects of Freeze–Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression
27. Human Bone Marrow- and Adipose Tissue-derived Mesenchymal Stromal Cells are Immunosuppressive In vitro and in a Humanized Allograft Rejection Model
28. No Evidence for Circulating Mesenchymal Stem Cells in Patients with Organ Injury
29. Limited Efficacy of Immunosuppressive Drugs on CD8+ T Cell-Mediated and Natural Killer Cell-Mediated Lysis of Human Renal Tubular Epithelial Cells
30. Mesenchymal Stem Cells Induce an Inflammatory Response After Intravenous Infusion
31. Effects of Hypoxia on the Immunomodulatory Properties of Adipose Tissue-Derived Mesenchymal Stem cells
32. Mesenchymal stem cells derived from adipose tissue are not affected by renal disease
33. Human Mesenchymal Stem Cells Are Susceptible to Lysis by CD8+ T Cells and NK Cells
34. Human Adipose Tissue-Derived Mesenchymal Stem Cells Induce Explosive T-Cell Proliferation
35. Characterization of Rabbit Antithymocyte Globulins-Induced CD25+ Regulatory T Cells From Cells of Patients With End-Stage Renal Disease
36. Monitoring of the Immunomodulatory Effect of CP-690,550 by Analysis of the JAK/STAT Pathway in Kidney Transplant Patients
37. Inadequate Immune Regulatory Function of CD4+CD25bright+FoxP3+ T Cells in Heart Transplant Patients who Experience Acute Cellular Rejection
38. Donor-Derived Mesenchymal Stem Cells Suppress Alloreactivity of Kidney Transplant Patients
39. The Effect of the JAK Inhibitor CP-690,550 on Peripheral Immune Parameters in Stable Kidney Allograft Patients
40. Susceptibility of Human Mesenchymal Stem Cells to Tacrolimus, Mycophenolic Acid, and Rapamycin
41. FOXP3 mRNA expression analysis in the peripheral blood and allograft of heart transplant patients
42. Interleukin-21: An Interleukin-2 Dependent Player in Rejection Processes
43. Intragraft FOXP3 mRNA Expression Reflects Antidonor Immune Reactivity in Cardiac Allograft Patients
44. Differential Effect of Calcineurin Inhibitors, Anti-CD25 Antibodies and Rapamycin on the Induction of FOXP3 in Human T Cells
45. Characterization of Rabbit Antithymocyte Globulins-Induced CD25+ Regulatory T Cells From Cells of Patients With End-Stage Renal Disease.
46. Inadequate Immune Regulatory Function of CD4+CD25bright+FoxP3+ T Cells in Heart Transplant Patients who Experience Acute Cellular Rejection.
47. Human Mesenchymal Stem Cells Are Susceptible to Lysis by CD8+T Cells and NK Cells
48. Characterization of Rabbit Antithymocyte Globulins-Induced CD25Regulatory T Cells From Cells of Patients With End-Stage Renal Disease
49. Inadequate Immune Regulatory Function of CD4CD25brightFoxP3T Cells in Heart Transplant Patients who Experience Acute Cellular Rejection
50. The Effect of the JAK Inhibitor CP-690,550 on Peripheral Immune Parameters in Stable Kidney Allograft Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.